Indian J Dermatol Venereol Leprol 68(1):1315 Barbaud A, Collet E, Milpied B, Assier H, Staumont D, Avenel-Audran M, Grange A, Amarger S, Girardin P, Guinnepain MT, Truchetet F, Lasek A, Waton J (2013) A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions
First, the schedule increases by exactly 2.5 mg every four weeks
Sample Volume Limitations Many projects are constrained by scarce or precious material (e.g., small tissue biopsies, limited plasma volume, rare cell populations)
Who should avoid using this medication
The evidence regarding intravenous (IV) glutathione for skin tone or pigmentation improvement is minimal and contradictory, raising significant concerns about the potential adverse effects of this administration method